CTL Medical Corporation, a Dallas, Texas-based medical device manufacturing and service company, announced it has signed a definitive agreement to acquire AccelSPINE®, a nationally recognized medical device designer and manufacturer headquartered in Dallas. The acquisition went into effect January 25, 2016.
“AccelSPINE is a leader in our industry, and they have a proven track record of producing exceptional medical products. Acquiring AccelSPINE not only helps advance our global growth strategy, but it also helps us meet the needs of our growing customer base,” said Andy Choi, Chief Business Development Officer of CTL Medical Corporation.
AccelSPINE is a privately held company that was established in October 2010 by then President & CEO, Daniel Chon. The company chose its Dallas headquarters in March 2011 to leverage strategic business initiatives and has since seen significant growth.
In 2015, AccelSPINE received its CE Marking and EN ISO 13485 certification. This certification allowed AccelSPINE to expand its customer base to the 28 countries that make up the European Union and five additional countries that adhere to European Union regulations.
While CTL Medical Corporation wholly owns AccelSPINE, the AccelSPINE brand will remain intact until the integration is complete and appropriate regulatory measures have been met. CTL Medical Corporation will retain all of AccelSPINE’s current employees and executives, and anticipates a significant increase in workforce by early 2017.
CTL Medical Corporation